These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


438 related items for PubMed ID: 17074265

  • 21. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.
    Ohkado A, Aguiman L, Adlawan S, Baring E, Quirante O, Suchi M, Endo S, Fujiki A, Mori T.
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):283-9. PubMed ID: 16562708
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW, Abate G, Lakew M, Goshu S, Aseffa A.
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
    Sevim T, Ataç G, Güngör G, Törün I, Aksoy E, Gemci, Tahaoglu K.
    Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
    Ormerod LP.
    Br Med Bull; 2005 Apr; 73-74():17-24. PubMed ID: 15956357
    [Abstract] [Full Text] [Related]

  • 30. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
    Ye Z, Pei X, Yang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811
    [Abstract] [Full Text] [Related]

  • 33. Drug-resistant tuberculosis: past, present, future.
    Chiang CY, Centis R, Migliori GB.
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Tuberculosis in Europe: a problem of drug resistance or much more?
    Carvalho AC, Migliori GB, Cirillo DM.
    Expert Rev Respir Med; 2010 Apr; 4(2):189-200. PubMed ID: 20406085
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.